1 / 9

Global Cell Isolation Market 2019-2023: Emerging Opportunities From Continuous Product Advancements

The global cell isolation market will grow at a CAGR of almost 19% during 2018-2023, and the market size will increase by USD 6.84 billion during 2019-2023. The marketu2019s growth momentum is expected to accelerate throughout the forecast period.

sarahbennu
Télécharger la présentation

Global Cell Isolation Market 2019-2023: Emerging Opportunities From Continuous Product Advancements

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global cell isolation market is expected to grow at a CAGR of close to 19% between 2019- 2023. The cell isolation market deals with the development of products used in the separation of biological components, including proteins, nucleic acids, protein complexes, chromatin, and other cells for further in-depth analysis. Cell isolation consumables and equipment are increasingly being deployed by a wide range of end-users including contract research organizations (CROs), pharmaceutical and biotechnology companies, academic institutes, hospitals, and diagnostic centers. For more Information get Free Sample Report With the rising prevalence of chronic diseases, cell isolation has begun to garner traction in recent years as it plays a critical role in the research and diagnostics of chronic health conditions. Cell isolation tools are deployed in drug discovery to generate recombinant protein therapeutics which can be used to treat a variety of health conditions, including cancer, genetic disorders, and autoimmune diseases. Market players are encouraging the use of cell isolation technique by offering products such as the Cancer Cell Isolation Kit from Thermo Fisher Scientific. Such products assist researchers in isolating cancer cells from biopsy samples. Advancements in the development of cell isolation consumables and other related products is a key trend that has been gaining importance in recent years. Market players are consistently focusing on upgrading their cell isolation systems with advanced automated solutions involving magnetic cell separation. Companies such as BD and QIAGEN are offering fully automated solutions to minimize the chances of contamination and allow the researchers to conduct a quick analysis. This is further expected to drive the sales of products leading to market growth during the forecast period. Regional Outlook The global cell isolation market spans across four major regions: North America, Europe, Asia, and ROW. The North America cell isolation market is expected to grow by USD 2.77 billion during 2019-2023.

  2. The US is expected to witness the fastest growth in the cell isolation market. The presence of several well-established market players and increasing investments in the thriving healthcare sector are key factors leading to the growth of the market. The cell isolation market in Canada is also showing strong growth due to the increasing government funding toward cell-based research. Competitive Outlook Merck KGaA operates in key business segments, including Healthcare, Life Science, and Performance Materials. The company has expanded its operations through a new laboratory in Singapore and a newly launched R&D facility in the US. The company has established a significant presence in the cell isolation market with the development of reagents such as Estapor Paramagnetic Microspheres, which help in the extraction of specific cells or microorganisms with the help of a simple magnet. Merck KGaA has significant presence in APAC, Europe, North America, Latin America, and Middle East and Africa. Get Full Report: Key Topics Covered: 1. Executive summary 1.1. Contribution of market under focus to the parent market 1.1.1. Parent market 1.1.2. Market in focus 1.2. Growth momentum 1.2.1. Year over year growth 1.3. Market share by region 1.4. Incremental growth 1.4.1. Global market growth 1.4.2. Contribution to the global market growth by region 1.5. Market share by product 1.6. Market share by end-user 1.7. Market share of key countries in 2018 1.8. Structure of the market in focus

  3. 1.8.1. Market concentration 1.8.2. Market maturity 1.8.3. Market participants 1.9. Factors that are driving demand 1.10. Challenges that affect market dynamics 1.11. Key trends that are impacting the market 2. Scope of the report 2.1. Preface 2.1.1. Market definition 2.1.2. Objectives 2.1.3. Notes and caveats 2.2. Currency conversion rates for US 3. Market landscape 3.1. Market ecosystem 3.1.1. Global healthcare market 3.1.2. Segments of global healthcare market 3.2. Market characteristics 3.2.1. Market characteristics analysis 3.3. Market segmentation analysis 4. Market sizing 4.1. Market definition 4.2. Market sizing 2018 4.3. Market size and forecast 2019-2023

  4. 4.3.1. Global market: Size and forecast 2018-2023 ($ millions) 4.3.2. Global market: Year-over-year growth 2019-2023 (%) 5. Five forces analysis 5.1. Five forces analysis 2018 5.2. Five forces analysis 2023 5.3. Bargaining power of buyers 5.4. Bargaining power of suppliers 5.5. Threat of new entrants 5.6. Threat of substitutes 5.7. Threats of rivalry 5.8. Market condition 6. Market segmentation by product 6.1. Market share by product 6.2. Comparison by product 6.3. Consumables 6.3.1. Consumables - Market size and forecast 2018-2023 ($ millions) 6.3.2. Consumables - Year-over-year growth 2019-2023 (%) 6.4. Instruments 6.4.1. Instruments - Market size and forecast 2018-2023 ($ millions) 6.4.2. Instruments - Year-over-year growth 2019-2023 (%) 6.5. Market opportunity by product 7. Customer landscape 7.1. Customer landscape analysis

  5. 8. Market segmentation by end-user 8.1. Market share by end-user 8.2. Comparison by end-user 8.3. AR 8.3.1. AR - Market size and forecast 2018-2023 ($ millions) 8.3.2. AR - Year-over-year growth 2019-2023 (%) 8.4. PB 8.4.1. PB - Market size and forecast 2018-2023 ($ millions) 8.4.2. PB - Year-over-year growth 2019-2023 (%) 8.5. CRO 8.5.1. CRO - Market size and forecast 2018-2023 ($ millions) 8.5.2. CRO - Year-over-year growth 2019-2023 (%) 8.6. Others 8.6.1. Others - Market size and forecast 2018-2023 ($ millions) 8.6.2. Others - Year-over-year growth 2019-2023 (%) 8.7. Market opportunity by end-user 9. Market segmentation by Geography 9.1. Market share by geography 9.2. Geographic comparison 9.3. North America 9.3.1. North America - Market size and forecast 2018-2023 ($ millions) 9.3.2. North America - Year-over-year growth 2019-2023 (%) 9.4. Europe

  6. 9.4.1. Europe - Market size and forecast 2018-2023 ($ millions) 9.4.2. Europe - Year-over-year growth 2019-2023 (%) 9.5. Asia 9.5.1. Asia - Market size and forecast 2018-2023 ($ millions) 9.5.2. Asia - Year-over-year growth 2019-2023 (%) 9.6. ROW 9.6.1. ROW - Market size and forecast 2018-2023 ($ millions) 9.6.2. ROW - Year-over-year growth 2019-2023 (%) 9.7. Key leading countries 9.8. Market opportunity 10. Decision framework 11. Drivers and challenges 11.1. Market drivers 11.1.1. Increasing prevalence of chronic diseases 11.1.2. Rise in demand for clinical diagnosis 11.1.3. Increasing funding in cell-based research 11.2. Market challenges 11.2.1. Lack of trained laboratory professionals 11.2.2. Technical challenges in cell separation techniques 11.2.3. Ethical issues regarding embryonic stem cell isolation 11.3. Impact of drivers and challenges 12. Market trends 12.1. Product advances

  7. 12.2. Growing adoption of genetic engineering in forensic research 12.3. Strategic alliances 13. Vendor landscape 13.1. Overview 13.2. Landscape disruption 13.3. Competitive Scenario 14. Vendor Analysis 14.1. Vendors covered 14.2. Vendor classification 14.3. Market positioning of vendors 14.4. Agilent Technologies Inc. 14.4.1. Vendor overview 14.4.2. Business segments 14.4.3. Organizational developments 14.4.4. Geographic focus 14.4.5. Segment focus 14.4.6. Key offerings 14.5. Becton Dickinson and Co. 14.5.1. Vendor overview 14.5.2. Product segments 14.5.3. Organizational developments 14.5.4. Geographic focus 14.5.5. Segment focus

  8. 14.5.6. Key offerings 14.6. Merck KGaA 14.6.1. Vendor overview 14.6.2. Business segments 14.6.3. Organizational developments 14.6.4. Key offerings 14.7. QIAGEN Group 14.7.1. Vendor overview 14.7.2. Business segments 14.7.3. Organizational developments 14.7.4. Geographic focus 14.7.5. Segment focus 14.7.6. Key offerings 14.8. Thermo Fisher Scientific Inc. 14.8.1. Vendor overview 14.8.2. Business segments 14.8.3. Organizational developments 14.8.4. Geographic focus 14.8.5. Segment focus 14.8.6. Key offerings 15. Appendix 15.1. Research Methodology 15.1.1. Research framework

  9. 15.1.2. Validation techniques employed for market sizing 15.1.3. Information sources 15.2. List of abbreviations 15.3. Definition of market positioning of vendors Browse Full Report - http://bit.ly/2YEqwTB

More Related